Cargando…

Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study

Microvascular and/or vasospastic anginas are relevant causes of ischemia with no obstructive coronary artery disease (INOCA) in patients after computed tomography coronary angiography (CTCA). OBJECTIVES: Our research has 2 objectives. The first is to undertake a diagnostic study, and the second is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidik, Novalia P, McEntegart, Margaret, Roditi, Giles, Ford, Thomas J, McDermott, Michael, Morrow, Andrew, Byrne, John, Adams, Jacqueline, Hargreaves, Allister, Oldroyd, Keith G, Stobo, David, Wu, Olivia, Messow, Claudia-Martina, McConnachie, Alex, Berry, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mosby 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029345/
https://www.ncbi.nlm.nih.gov/pubmed/31911341
http://dx.doi.org/10.1016/j.ahj.2019.11.015
_version_ 1783499149612679168
author Sidik, Novalia P
McEntegart, Margaret
Roditi, Giles
Ford, Thomas J
McDermott, Michael
Morrow, Andrew
Byrne, John
Adams, Jacqueline
Hargreaves, Allister
Oldroyd, Keith G
Stobo, David
Wu, Olivia
Messow, Claudia-Martina
McConnachie, Alex
Berry, Colin
author_facet Sidik, Novalia P
McEntegart, Margaret
Roditi, Giles
Ford, Thomas J
McDermott, Michael
Morrow, Andrew
Byrne, John
Adams, Jacqueline
Hargreaves, Allister
Oldroyd, Keith G
Stobo, David
Wu, Olivia
Messow, Claudia-Martina
McConnachie, Alex
Berry, Colin
author_sort Sidik, Novalia P
collection PubMed
description Microvascular and/or vasospastic anginas are relevant causes of ischemia with no obstructive coronary artery disease (INOCA) in patients after computed tomography coronary angiography (CTCA). OBJECTIVES: Our research has 2 objectives. The first is to undertake a diagnostic study, and the second is to undertake a nested, clinical trial of stratified medicine. DESIGN: A prospective, multicenter, randomized, blinded, sham-controlled trial of stratified medicine (NCT03477890) will be performed. All-comers referred for clinically indicated CTCA for investigation of suspected coronary artery disease (CAD) will be screened in 3 regional centers. Following informed consent, eligible patients with angina symptoms are enrolled before CTCA and remain eligible if CTCA excludes obstructive CAD. Diagnostic study: Invasive coronary angiography involving an interventional diagnostic procedure (IDP) to assess for disease endotypes: (1) angina due to obstructive CAD (fractional flow reserve ≤0.80); (2) microvascular angina (coronary flow reserve <2.0 and/or index of microvascular resistance >25); (3) microvascular angina due to small vessel spasm (acetylcholine); (4) vasospastic angina due to epicardial coronary spasm (acetylcholine); and (5) noncoronary etiology (normal coronary function). The IDP involves direct invasive measurements using a diagnostic coronary guidewire followed by provocation testing with intracoronary acetylcholine. The primary outcome of the diagnostic study is the reclassification of the initial CTCA diagnosis based on the IDP. Stratified medicine trial: Participants are immediately randomized 1:1 in the catheter laboratory to therapy stratified by endotype (intervention group) or not (control group). The primary outcome of the trial is the mean within-subject change in Seattle Angina Questionnaire score at 6 months. Secondary outcomes include safety, feasibility, diagnostic utility (impact on diagnosis and certainty), and clinical utility (impact on treatment and investigations). Health status assessments include quality of life, illness perception, anxiety-depression score, treatment satisfaction, and physical activity. Participants who are not randomized will enter a follow-up registry. Health and economic outcomes in the longer term will be assessed using electronic patient record linkage. VALUE: CorCTCA will prospectively characterize the prevalence of disease endotypes in INOCA and determine the clinical value of stratified medicine in this population.
format Online
Article
Text
id pubmed-7029345
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mosby
record_format MEDLINE/PubMed
spelling pubmed-70293452020-03-01 Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study Sidik, Novalia P McEntegart, Margaret Roditi, Giles Ford, Thomas J McDermott, Michael Morrow, Andrew Byrne, John Adams, Jacqueline Hargreaves, Allister Oldroyd, Keith G Stobo, David Wu, Olivia Messow, Claudia-Martina McConnachie, Alex Berry, Colin Am Heart J Article Microvascular and/or vasospastic anginas are relevant causes of ischemia with no obstructive coronary artery disease (INOCA) in patients after computed tomography coronary angiography (CTCA). OBJECTIVES: Our research has 2 objectives. The first is to undertake a diagnostic study, and the second is to undertake a nested, clinical trial of stratified medicine. DESIGN: A prospective, multicenter, randomized, blinded, sham-controlled trial of stratified medicine (NCT03477890) will be performed. All-comers referred for clinically indicated CTCA for investigation of suspected coronary artery disease (CAD) will be screened in 3 regional centers. Following informed consent, eligible patients with angina symptoms are enrolled before CTCA and remain eligible if CTCA excludes obstructive CAD. Diagnostic study: Invasive coronary angiography involving an interventional diagnostic procedure (IDP) to assess for disease endotypes: (1) angina due to obstructive CAD (fractional flow reserve ≤0.80); (2) microvascular angina (coronary flow reserve <2.0 and/or index of microvascular resistance >25); (3) microvascular angina due to small vessel spasm (acetylcholine); (4) vasospastic angina due to epicardial coronary spasm (acetylcholine); and (5) noncoronary etiology (normal coronary function). The IDP involves direct invasive measurements using a diagnostic coronary guidewire followed by provocation testing with intracoronary acetylcholine. The primary outcome of the diagnostic study is the reclassification of the initial CTCA diagnosis based on the IDP. Stratified medicine trial: Participants are immediately randomized 1:1 in the catheter laboratory to therapy stratified by endotype (intervention group) or not (control group). The primary outcome of the trial is the mean within-subject change in Seattle Angina Questionnaire score at 6 months. Secondary outcomes include safety, feasibility, diagnostic utility (impact on diagnosis and certainty), and clinical utility (impact on treatment and investigations). Health status assessments include quality of life, illness perception, anxiety-depression score, treatment satisfaction, and physical activity. Participants who are not randomized will enter a follow-up registry. Health and economic outcomes in the longer term will be assessed using electronic patient record linkage. VALUE: CorCTCA will prospectively characterize the prevalence of disease endotypes in INOCA and determine the clinical value of stratified medicine in this population. Mosby 2020-03 /pmc/articles/PMC7029345/ /pubmed/31911341 http://dx.doi.org/10.1016/j.ahj.2019.11.015 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sidik, Novalia P
McEntegart, Margaret
Roditi, Giles
Ford, Thomas J
McDermott, Michael
Morrow, Andrew
Byrne, John
Adams, Jacqueline
Hargreaves, Allister
Oldroyd, Keith G
Stobo, David
Wu, Olivia
Messow, Claudia-Martina
McConnachie, Alex
Berry, Colin
Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study
title Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study
title_full Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study
title_fullStr Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study
title_full_unstemmed Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study
title_short Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study
title_sort rationale and design of the british heart foundation (bhf) coronary microvascular function and ct coronary angiogram (corctca) study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029345/
https://www.ncbi.nlm.nih.gov/pubmed/31911341
http://dx.doi.org/10.1016/j.ahj.2019.11.015
work_keys_str_mv AT sidiknovaliap rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT mcentegartmargaret rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT roditigiles rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT fordthomasj rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT mcdermottmichael rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT morrowandrew rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT byrnejohn rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT adamsjacqueline rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT hargreavesallister rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT oldroydkeithg rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT stobodavid rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT wuolivia rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT messowclaudiamartina rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT mcconnachiealex rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy
AT berrycolin rationaleanddesignofthebritishheartfoundationbhfcoronarymicrovascularfunctionandctcoronaryangiogramcorctcastudy